TY - JOUR
T1 - Tackling antimicrobial resistance across sub-Saharan Africa
T2 - current challenges and implications for the future
AU - Godman, Brian
AU - Egwuenu, Abiodun
AU - Wesangula, Evelyn
AU - Schellack, Natalie
AU - Kalungia, Aubrey Chichonyi
AU - Tiroyakgosi, Celda
AU - Kgatlwane, Joyce
AU - Mwita, Julius C
AU - Patrick, Okwen
AU - Niba, Loveline
AU - Amu, Adefolarin
AU - Oguntade, Racheal
AU - Alabi, Mobolaji
AU - Ncube, Nondumiso
AU - Sefah, Israel
AU - Acolatse, Joseph
AU - Incoom, Robert
AU - Guantai, Anastasia
AU - Oluka, Margaret
AU - Opanga, Sylvia
AU - Chikowe, Ibrahim
AU - Khuluza, Felix
AU - Chiumia, Francis
AU - Jana, Collins
AU - Kalemeera, Francis
AU - Hango, Ester
AU - Fadare, Joseph
AU - Ogunleye, Olayinka
AU - Meyer, Johanna
AU - Malande, Oliver
AU - Kibuule, Dan
AU - Massele, Amos
AU - Ebruke, Bernard
AU - Kapona, Otridah
AU - Zaranyika, Trust
AU - Bwakura-Dangarembizi, Mutsa B
AU - Kujinga, Tapiwanashe
AU - Saleem, Zikria
AU - Kurdi, Amanj
AU - Shahwan, Moyad
AU - Jairoun, Ammar Abdulrahman
AU - Wale, Janney
AU - Brink, Adrian
PY - 2022/9/5
Y1 - 2022/9/5
N2 - Introduction: Antimicrobial resistance (AMR) is a concern as this increases morbidity, mortality, and costs, with sub-Saharan Africa having the highest rates globally. Concerns with rising AMR have resulted in international, Pan-African, and country activities including the development of national action plans (NAPs). However, there is variable implementation across Africa with key challenges persisting. Areas covered: Consequently, there is an urgent need to document current NAP activities and challenges across sub-Saharan Africa to provide future guidance. This builds on a narrative review of the literature. Expert Opinion: All surveyed sub-Saharan African countries have developed their NAPs; however, there is variable implementation. Countries including Botswana and Namibia are yet to officially launch their NAPs with Eswatini only recently launching its NAP. Cameroon is further ahead with its NAP than these countries; though there are concerns with implementation. South Africa appears to have made the greatest strides with implementing its NAP including regular monitoring of activities and instigation of antimicrobial stewardship programs. Key challenges remain across Africa. These include available personnel, expertise, capacity, and resources to undertake agreed NAP activities including active surveillance, lack of focal points to drive NAPs, and competing demands and priorities including among donors. These challenges are being addressed, with further co-ordinated efforts needed to reduce AMR.
AB - Introduction: Antimicrobial resistance (AMR) is a concern as this increases morbidity, mortality, and costs, with sub-Saharan Africa having the highest rates globally. Concerns with rising AMR have resulted in international, Pan-African, and country activities including the development of national action plans (NAPs). However, there is variable implementation across Africa with key challenges persisting. Areas covered: Consequently, there is an urgent need to document current NAP activities and challenges across sub-Saharan Africa to provide future guidance. This builds on a narrative review of the literature. Expert Opinion: All surveyed sub-Saharan African countries have developed their NAPs; however, there is variable implementation. Countries including Botswana and Namibia are yet to officially launch their NAPs with Eswatini only recently launching its NAP. Cameroon is further ahead with its NAP than these countries; though there are concerns with implementation. South Africa appears to have made the greatest strides with implementing its NAP including regular monitoring of activities and instigation of antimicrobial stewardship programs. Key challenges remain across Africa. These include available personnel, expertise, capacity, and resources to undertake agreed NAP activities including active surveillance, lack of focal points to drive NAPs, and competing demands and priorities including among donors. These challenges are being addressed, with further co-ordinated efforts needed to reduce AMR.
KW - antimicrobial resistance
KW - antimicrobial stewardship programmes
KW - antimicrobial surveillance
KW - national action plans
KW - sub-Saharan Africa
KW - resources
KW - utilisation
U2 - 10.1080/14740338.2022.2106368
DO - 10.1080/14740338.2022.2106368
M3 - Article
SN - 1474-0338
VL - 21
SP - 1089
EP - 1111
JO - Expert Opinion on Drug Safety
JF - Expert Opinion on Drug Safety
IS - 8
ER -